Jeff Yass’s Pulmonx LUNG Stock Holding History

Jeff Yass’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,700	Closed	-$193K	–	12901
2023 Q3	$193K	Buy	+18,700	New	+$217K	﹤0.01%	10270
2023 Q2	–	Sell	-171,900	Closed	-$1.92M	–	12700
2023 Q1	$1.92M	Buy	171,900 +158,500	+1,183%	+$1.56M	﹤0.01%	5231
2022 Q4	$113K	Buy	13,400 +800	+6%	+$7.61K	﹤0.01%	10838
2022 Q3	$210K	Buy	+12,600	New	+$232K	﹤0.01%	10717
2022 Q2	–	Sell	-30,200	Closed	-$749K	–	13511
2022 Q1	$749K	Buy	+30,200	New	+$780K	﹤0.01%	7895
2021 Q4	–	Sell	-22,300	Closed	-$802K	–	13562
2021 Q3	$802K	Buy	+22,300	New	+$877K	﹤0.01%	8131
2021 Q2	–	Sell	-5,100	Closed	-$233K	–	12968
2021 Q1	$233K	Buy	+5,100	New	+$293K	﹤0.01%	11120

Other funds holding LUNG

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Jeff Yass's LUNG Position: Q2 2026 in Review

Jeff Yass reduced its Pulmonx (LUNG) stake by 28% in Q2 2026, selling an estimated $34K and leaving 64,373 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12610.

Jeff Yass first reported a position in LUNG in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.51M in Q1 2022. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

Jeff Yass held 64,373 shares of Pulmonx worth $83.7K as of Q2 2026.
Jeff Yass sold 24,696 Pulmonx shares in Q2 2026, an estimated $34K.
Pulmonx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12610 holding.
Jeff Yass first reported a position in Pulmonx in Q1 2022 and has held it in 18 quarters since.
Jeff Yass's Pulmonx position peaked at $4.51M in Q1 2022.
108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.